Trademark: 79176026
Word
CANTX
Status Date
Friday, June 17, 2016
Filing Date
Thursday, May 21, 2015
Abandoned Date
Monday, May 23, 2016
5 House mark for pharmaceutical preparations for the treatment of cancer, excluding use as a product mark for pharmaceuticals for colon cancer or cancer of the gastrointestinal system
42 Scientific research services; research and development of new products; advisory services relating to scientific research; biotechnology research; medical research; chemical research
The mark consists of the term CANTX, with the letters TX appearing inside of a broken circle formed by three overlapping sections.
Color is not claimed as a feature of the mark.
Aug 14, 2022
New Representative At Ib Received
Jul 8, 2017
Final Decision Transaction Processed By Ib
Jun 19, 2017
Final Disposition Notice Sent To Ib
Jun 17, 2017
Final Disposition Notice Created, To Be Sent To Ib
Apr 28, 2017
Notification Of Possible Opposition - Processed By Ib
Apr 12, 2017
Notification Of Possible Opposition Sent To Ib
Apr 12, 2017
Notification Of Possible Opposition Created, To Be Sent To Ib
Jun 17, 2016
Abandonment Notice Mailed - Failure To Respond
Jun 17, 2016
Abandonment - Failure To Respond Or Late Response
Dec 11, 2015
Refusal Processed By Ib
Nov 21, 2015
Application Filing Receipt Mailed
Nov 20, 2015
Non-Final Action Mailed - Refusal Sent To Ib
Nov 20, 2015
Refusal Processed By Mpu
Nov 19, 2015
Non-Final Action (Ib Refusal) Prepared For Review
Nov 18, 2015
Non-Final Action Written
Nov 17, 2015
Assigned To Examiner
Nov 17, 2015
New Application Office Supplied Data Entered In Tram
Nov 16, 2015
Limitation From Original Application Entered
Nov 15, 2015
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
